163 related articles for article (PubMed ID: 7043679)
1. Effect of chronic tolbutamide administration on normal and obese-hyperglycemic mice: evidence for post-receptor potentiation of insulin action.
Poyet C; Feldman JM
Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):355-76. PubMed ID: 7043679
[TBL] [Abstract][Full Text] [Related]
2. Effect of age on hepatocyte and soleus muscle insulin receptor binding in lean and genetically obese diabetic (ob/ob) mice.
Lord JM; Atkins TW
Diabetes Res; 1985 Sep; 2(5):259-65. PubMed ID: 3905189
[TBL] [Abstract][Full Text] [Related]
3. Effect of sulphonylurea derivatives, SPC-703 and tolbutamide, on insulin binding by isolated rat adipocytes.
Skowroński R; Madrala A; Angielski S
Acta Biochim Pol; 1984; 31(2):251-62. PubMed ID: 6385586
[TBL] [Abstract][Full Text] [Related]
4. The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob mice.
Moritoh Y; Takeuchi K; Asakawa T; Kataoka O; Odaka H
Eur J Pharmacol; 2009 Jan; 602(2-3):448-54. PubMed ID: 19038243
[TBL] [Abstract][Full Text] [Related]
5. Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice.
Moritoh Y; Takeuchi K; Asakawa T; Kataoka O; Odaka H
Eur J Pharmacol; 2008 Jul; 588(2-3):325-32. PubMed ID: 18499100
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
[TBL] [Abstract][Full Text] [Related]
7. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
Piercy V; Toseland CD; Turner NC
Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
[TBL] [Abstract][Full Text] [Related]
8. 2-Deoxyglucose tissue levels and insulin levels following tolazamide dosing in normal and obese mice.
Skillman CA; Fletcher HP
Exp Clin Endocrinol; 1986 Aug; 87(3):288-98. PubMed ID: 3536534
[TBL] [Abstract][Full Text] [Related]
9. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
[TBL] [Abstract][Full Text] [Related]
10. A stimulatory effect of tolbutamide on the insulin-mediated glucose uptake in subjects with impaired glucose tolerance (IGT).
Schulz B; Ratzmann KP; Heinke P; Besch W
Exp Clin Endocrinol; 1983 Aug; 82(2):222-31. PubMed ID: 6354732
[TBL] [Abstract][Full Text] [Related]
11. [Insulin receptors-a review (author's transl)].
Freychet P
Diabete Metab; 1975 Mar; 1():57-68. PubMed ID: 791721
[TBL] [Abstract][Full Text] [Related]
12. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
13. Antihyperglycaemic effect of saccharin in diabetic ob/ob mice.
Bailey CJ; Day C; Knapper JM; Turner SL; Flatt PR
Br J Pharmacol; 1997 Jan; 120(1):74-8. PubMed ID: 9117102
[TBL] [Abstract][Full Text] [Related]
14. Vanadate enhances but does not normalize glucose transport and insulin receptor phosphorylation in skeletal muscle from obese women with gestational diabetes mellitus.
Shao J; Catalano PM; Yamashita H; Ishizuka T; Friedman JE
Am J Obstet Gynecol; 2000 Nov; 183(5):1263-70. PubMed ID: 11084576
[TBL] [Abstract][Full Text] [Related]
15. Cellular loci of sulfonylurea actions.
Lebovitz HE
Diabetes Care; 1984; 7 Suppl 1():67-71. PubMed ID: 6376031
[TBL] [Abstract][Full Text] [Related]
16. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
Jetton TL; Liang Y; Cincotta AH
Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
Yamanaka M; Itakura Y; Inoue T; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397
[TBL] [Abstract][Full Text] [Related]
18. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
19. Long-term effect of fish oil diet on basal and stimulated plasma glucose and insulin levels in ob/ob mice.
Steerenberg PA; Beekhof PK; Feskens EJ; Lips CJ; Höppener JW; Beems RB
Diabetes Nutr Metab; 2002 Aug; 15(4):205-14. PubMed ID: 12416657
[TBL] [Abstract][Full Text] [Related]
20. Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob/ob mice.
Fromenty B; Vadrot N; Massart J; Turlin B; Barri-Ova N; Lettéron P; Fautrel A; Robin MA
J Pharmacol Exp Ther; 2009 Oct; 331(1):23-34. PubMed ID: 19587315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
